Veterinary Diagnostics Revenue Increasing Faster Than Overall IVD
|
By LabMedica International staff writers Posted on 06 Jan 2014 |
Veterinary diagnostics, at nearly USD 2 billion dollars, represent a supplementary but increasingly attractive course of market development for companies active in the USD 55 billion in vitro diagnostics (IVD) sector.
The findings were published in a new report by Kalorama Information (New York, NY, USA). Analyst Emil Salazar, explained that companies entering the veterinary diagnostics market benefit from lower regulatory demands, ready applications of medical diagnostic product platforms, and generally greater opportunities for revenue growth.
According to Emil Salazar, the past year visited the US IVD market with rigid cuts in lab test reimbursements and a regulatory rollout of the Affordable Care Act (ACA) that did little to instill industry confidence. Cost drivers in medical spending were able to only in part offset such market disturbances, and generate national IVD market growth of around 3%. Quietly outperforming its larger sister market, the US veterinary diagnostics market grew by about 5% in 2013.
Metrics refer to a company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). A metric can be used to show a company's profitability, but not its cash flow, EBITDA, earnings per share, or any other financial measures. Several metrics support the projection of veterinary diagnostics market growth: veterinary lab testing service revenue, rapid assay sales, and veterinary lab requisition volumes under leaders IDEXX (Westbrook, MN, USA) and VCA Antech (Los Angeles, CA, USA). Trends in these metrics reflect the base conditions in demand for veterinary testing by also excluding companies’ sales or placements of capital instrumentation at veterinary practices.
The fundaments of the veterinary diagnostics market in the United States were tested by a severe decline in consumer spending on pets during the economic recession. Typically a growth sector, veterinary practices were challenged for growth between 2009 and 2011. Subsequent recovery in the economy and consumer confidence reversed the fortunes of the veterinary care industry, and saw renewed, consistent growth in the veterinary diagnostics market.
The US market for pet care products and veterinary services is dependent upon a customer base of upper middle-income to affluent pet owners. "The recovery of the veterinary services market in recent years was aided in large part by the increasing role of higher income households, who are also more likely to pay for consistent and new vet lab testing," explained Emil Salazar. While veterinary office visits may rise only slightly (or even fall) in some years, test costs are increasing substantially with greater product complexity and growing reliance on IVD products during episodes of veterinary care.
"Future veterinary diagnostics market growth will depend upon the development of markets for more sophisticated products such as molecular diagnostic tests and increasing testing intensity as instrument placements decline in saturated markets," Emil Salazar said.
Kalorama Information’s report, The World Market for Veterinary Diagnostics, provides more information including breakouts for various segments of veterinary diagnostics, and discussions of trends in the industry. Profiles of key competitors are also included.
Related Links:
Kalorama Information
IDEXX
VCA Antech
The findings were published in a new report by Kalorama Information (New York, NY, USA). Analyst Emil Salazar, explained that companies entering the veterinary diagnostics market benefit from lower regulatory demands, ready applications of medical diagnostic product platforms, and generally greater opportunities for revenue growth.
According to Emil Salazar, the past year visited the US IVD market with rigid cuts in lab test reimbursements and a regulatory rollout of the Affordable Care Act (ACA) that did little to instill industry confidence. Cost drivers in medical spending were able to only in part offset such market disturbances, and generate national IVD market growth of around 3%. Quietly outperforming its larger sister market, the US veterinary diagnostics market grew by about 5% in 2013.
Metrics refer to a company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). A metric can be used to show a company's profitability, but not its cash flow, EBITDA, earnings per share, or any other financial measures. Several metrics support the projection of veterinary diagnostics market growth: veterinary lab testing service revenue, rapid assay sales, and veterinary lab requisition volumes under leaders IDEXX (Westbrook, MN, USA) and VCA Antech (Los Angeles, CA, USA). Trends in these metrics reflect the base conditions in demand for veterinary testing by also excluding companies’ sales or placements of capital instrumentation at veterinary practices.
The fundaments of the veterinary diagnostics market in the United States were tested by a severe decline in consumer spending on pets during the economic recession. Typically a growth sector, veterinary practices were challenged for growth between 2009 and 2011. Subsequent recovery in the economy and consumer confidence reversed the fortunes of the veterinary care industry, and saw renewed, consistent growth in the veterinary diagnostics market.
The US market for pet care products and veterinary services is dependent upon a customer base of upper middle-income to affluent pet owners. "The recovery of the veterinary services market in recent years was aided in large part by the increasing role of higher income households, who are also more likely to pay for consistent and new vet lab testing," explained Emil Salazar. While veterinary office visits may rise only slightly (or even fall) in some years, test costs are increasing substantially with greater product complexity and growing reliance on IVD products during episodes of veterinary care.
"Future veterinary diagnostics market growth will depend upon the development of markets for more sophisticated products such as molecular diagnostic tests and increasing testing intensity as instrument placements decline in saturated markets," Emil Salazar said.
Kalorama Information’s report, The World Market for Veterinary Diagnostics, provides more information including breakouts for various segments of veterinary diagnostics, and discussions of trends in the industry. Profiles of key competitors are also included.
Related Links:
Kalorama Information
IDEXX
VCA Antech
Latest Industry News
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
- GSI Group Acquires Blood Processing Equipment Manufacturer GenesisBPS
- ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases
- Lumiquick Acquires Aoxre to Expand Global IVD and Research Capabilities
- Lunit and Agilent Partner to Develop AI-Powered Cancer Diagnostics
- Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more




 assay.jpg)



